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The regulation and control of gene expression in response to differing environmental stimuli is
crucial for successful pathogen adaptation and persistence. The regulatory gene vru of
Streptococcus uberis encodes a stand-alone response regulator with similarity to the Mga of
group A Streptococcus. Mga controls expression of a number of important virulence determinants.
Experimental intramammary challenge of dairy cattle with a mutant of S. uberis carrying an
inactivating lesion in vru showed reduced ability to colonize the mammary gland and an inability to
induce clinical signs of mastitis compared with the wild-type strain. Analysis of transcriptional
differences of gene expression in the mutant, determined by microarray analysis, identified a
number of coding sequences with altered expression in the absence of Vru. These consisted of
known and putative virulence determinants, including Lbp (Sub0145), SclB (Sub1095), PauA
(Sub1785) and hasA (Sub1696).
INTRODUCTION
Improvements in milking hygiene, routine dry cow therapy
and culling of persistently infected animals have significantly
reduced mastitis rates caused by Streptococcus agalactiae and
Staphylococcus aureus (Hillerton et al., 1995); however, the
same is not the case for infections caused by pathogens
from environmental sources, namely Escherichia coli and
Streptococcus uberis. S. uberis is an opportunistic pathogen,
responsible for a significant proportion of clinical cases of
mastitis in the UK, and remains one of the major causative
agents of bovine mastitis worldwide (Botrel et al., 2010;
Bradley et al., 2007; Hillerton et al., 1993; Olde Riekerink
et al., 2008; Shum et al., 2009). S. uberis has been isolated
from a range of environmental sources, including soil,
pasture, faeces and bedding materials (Bramley, 1982; Field
et al., 2003; Lopez-Benavides et al., 2007; Zadoks et al.,
2005), and other bovine host sites including skin, genital
tract, gastrointestinal tract and tonsils, all of which are
colonized asymptomatically (Cruz Colque et al., 1993;
Epperson et al., 1993; Kruze & Bramley, 1982).
The ability of S. uberis to adapt to such varied niches is
likely to contribute to the organisms’ continued persistence
within dairy systems. Such adaptation is likely to be
influenced by regulatory genes, and the characterization of
their role can be used to identify specific gene subsets of
relevance to different conditions. Furthermore, interference
with the activity of such regulatory elements may provide
novel targets against which control strategies to prevent or
eliminate bacterial infections may be mounted. Streptococcus
pyogenes [group A Streptococcus (GAS)] is evolutionarily
closely related to S. uberis (Ward et al., 2009), and is spe-
cifically a human pathogen with a remarkable ability to
cause a wide range of infections, ranging from pharyngitis to
necrotizing fasciitis and streptococcal toxic-shock syndrome
(Cunningham, 2000; Johansson et al., 2010). Unlike many
other prokaryotes, which co-ordinate the regulation of gene
expression through alternative sigma factors, GAS favours
Abbreviations: CDS, coding sequence; GAS, group A Streptococcus;
HRP, horseradish peroxidase.
The GEO series accession number for the microarray data discussed in
this paper is GSE33186.
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control through transcriptional regulators, which can act as
both activators and repressors, and can be categorized as
either response regulators or two-component signal trans-
duction systems (TCSs) (Kreikemeyer et al., 2003; Opdyke
et al., 2001). Analysis of GAS genomes has revealed around
13 TCSs, many of which contribute to bacterial virulence.
These contain a sensor kinase that responds to changes
in signal by phosphorylation of a linked DNA-binding
response regulator to alter patterns of gene expression
(Hondorp & McIver, 2007). GAS also frequently use so
called ‘stand-alone’ response regulators that have been
shown to control multiple virulence genes. The positive
transcriptional regulator Mga (Caparon & Scott, 1987)
activates expression of a number of GAS virulence-related
genes, including M protein (emm) (Perez-Casal et al., 1991),
fibronectin-binding protein (fba) (Terao et al., 2001),
collagen-like protein (sclA) (Rasmussen et al., 2000), a C5a
peptidase (scpA) (Chen et al., 1993) and M-like immu-
noglobulin-binding proteins (including mrp and enn)
(Podbielski et al., 1995, 1996).
Coding sequences (CDSs) homologous to the regulator
Mga and some of the regulated CDSs (in particular M
protein and C5a peptidase) have been identified in other
streptococci of human and/or animal origin, including
Streptococcus pneumoniae, Streptococcus dysgalactiae and
Streptococcus iniae (Locke et al., 2008; Tettelin et al., 2001;
Vasi et al., 2000). As such, these sequences can be
postulated to represent a conserved regulon of products
linked to early colonization and infection in a range of
streptococcal species.
Analysis of the S. uberis genome has identified a number
of potential regulatory elements, one of which, sub0144
(vru); shows some similarity to Mga of S. pyogenes. The
translation product of the putative transcriptional regu-
lator (Vru) displays 38% sequence identity (57% similar-
ity) to Mgc, a transcriptional regulator common to group
C streptococci (GCS) (Geyer & Schmidt, 2000), and 33%
identity (56% similarity) to Mga, the counterpart in GAS.
The S. uberis 0140J Vru CDS displays good homology to
functional regions of these regulators extending over the
fourth crucial helix–turn–helix DNA-binding domain
identified in GAS Mga (McIver & Myles, 2002), supporting
a putative DNA-binding mode of action in S. uberis.
However unlike GAS and GCS, S. uberis lacks many of
virulence determinants typically controlled via Mga/Mgc
(Ward et al., 2009), although CDSs with limited similarity
to both C5a peptidase (sub1154) and collagen-like protein
(sub1095) have been identified (Ward et al., 2009). Both of
these sequences, along with that of sub0145, shown
previously to encode a lactoferrin-binding protein, have
been demonstrated to play a role in virulence of S. uberis;
in each case the absence of the gene product reduces the
ability to colonize and/or cause disease in the target species
(Leigh et al., 2010).
In this study, we investigated the role of Vru in vivo and the
effect of its absence on transcriptional control of gene
expression using a custom-designed genome-wide micro-
array.
METHODS
Bacterial strains and media. S. uberis strain 0140J (strain ATCC
BAA-854/0140J), originally isolated from a clinical case of bovine
mastitis in the UK, was used throughout this study. The sub0145,
sub0826, sub0888 and sub1095 mutants were isolated following PCR
screening of an S. uberis 0140J/pGh9:ISS1 mutant bank, as previously
described (Egan et al., 2010; Leigh et al., 2010; Ward et al., 2001). The
vru mutant, containing an insertional disruption in the reverse
orientation to the CDS, was isolated from the same mutant bank
using a phenotypic screening method by identification of zones of
clearing on Todd–Hewitt agar containing skimmed milk (1%, v/v)
and bovine plasminogen, as previously described (Ward et al., 2003).
Southern analysis and DNA sequencing were used to confirm the
nature and location of mutation events (data not shown). Strains
were routinely grown in Todd–Hewitt broth (THB) (Oxoid) and
plated on sheep blood agar containing 1% (w/v) aesculin (ABA) at
37 uC.
Isolation of bacterial RNA. Aliquots of bacterial culture (15–20 ml)
of S. uberis 0140J and vru mutant were harvested once cultures
reached OD550 0.42 for early exponential or OD550 0.75 for late-
exponential growth phase. Two volumes of RNAprotect Bacteria
Reagent (Qiagen) were immediately added to each sample and the
mixture was incubated for 5 min at room temperature. Samples were
centrifuged (5000 g, 10 min), the supernatant was discarded and
the cell pellets were stored at 280 uC until RNA extraction was
performed.
Total RNA was extracted following resuspension of the cells in 1 ml
RLT buffer (Qiagen) containing 1% (v/v) b-mercaptoethanol
(Sigma–Aldrich). Cells were mechanically disrupted in a Mini-
Beadbeater-8 (Biospec) using acid-washed glass beads (Sigma).
Following disruption, glass beads and cell debris were removed by
centrifugation (17 000 g, 10 s). Supernatants were removed and
mixed with an equal volume of 70% ethanol. Total RNA was
extracted using an RNeasy column (Qiagen) according to the
manufacturer’s instructions, with RNA finally eluted in 50 ml
nuclease-free water. Contaminating DNA was removed from the
samples by DNase treatment using a DNA-free DNase Treatment kit
(Ambion), and resulting samples were further purified by ethanol
precipitation. The integrity and quality of the RNA were determined
by gel electrophoresis and by spectrophotometry using an ND-1000
spectrophotometer (NanoDrop Technologies).
Design and hybridization to S. uberis 0140J gene expression
microarray. A custom-designed S. uberis 0140J DNA microarray was
generated and probed by Oxford Gene Technology (OGT). The array
encompassed the whole bacterial genome and was composed of 3780
features, with optimized 60-mer oligonucleotide probes printed in
triplicate. Two separate probes were designed to match each individual
gene determined from the S. uberis 0140J genome annotation (Ward
et al., 2009), with regions of homology discounted. Arrays were printed
on glass microscope slides, as described elsewhere (Hughes et al., 2001).
Fluorescently labelled probes for microarray hybridization were
generated from 500 ng total RNA using the MessageAmp II-Bacteria
RNA Amplification kit (Ambion) according to the manufacturer’s
instructions. A total of 5 mg of the resulting amplified antisense RNA
was purified using the RNeasy MinElute Cleanup kit (Qiagen) and
hybridization was performed using a Gene Expression Hybridization
kit (Agilent). Samples were labelled with either Cy3 or Cy5 N-
hydroxysuccinimide ester reactive dyes (GE healthcare) according to
S. A. Egan and others
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the manufacturer’s instructions, with sample combinations gener-
ated following a loop design (Townsend, 2003). Three independent
repetitions were performed of two growth-point comparisons, giving
a total of six microarray hybridizations. Cy3- and Cy5-labelled
probes were mixed together in the appropriate combinations, with the
fragmented RNA and hybridization buffer applied to the microarray
hybridization chamber (Agilent Technologies) and incubated at 65 uC
for 17 h with 10 r.p.m. rotation. Following hybridization, microarrays
were washed using Gene Expression Wash Buffer (Agilent
Technologies). Arrays were scanned on an Agilent C scanner at 5 mm
using the XDR function at 10%. The images were then feature-
extracted using Agilent feature extraction version 10.5.1.1 and the
GE2_105_Jan09 extraction protocol.
Bioinformatic and statistical analyses. The microarray data were
loess- and scale-normalized (Smyth & Speed, 2003), and analysed for
differential expression using limma (Smyth, 2004). Linear models
were fitted to the data to compare the vru mutant with the wild-type
0140J strain at both the early and late exponential growth phase. The
resultant P values were adjusted for the false discovery rate
(Benjamini & Hochberg, 1995). Expression values were visualized
using ProGenExpress (Watson, 2005). Genes were linked to Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways (Kanehisa &
Goto, 2000) and statistically enriched pathways identified using
CORNA (Wu & Watson, 2009). Sequence analysis of the intergenic and
promoter regions of the genes sub0144 (vru) and sub0145 (lbp) was
performed using Artemis (Rutherford et al., 2000) and BPROM from
Softberry sequence analysis tools (http://linux1.softberry.com/berry.
phtml?topic=bprom&group=programs&subgroup=gfindb).
Challenge of lactating dairy cows with S. uberis and analysis of
milk samples. The requirement of a functional vru gene for S. uberis
strain 0140J virulence was determined by intramammary challenge of
Holstein–Friesian cows, 2–10 weeks into their first lactation, with
either S. uberis 0140J or Vru mutant. Animal selection was based on
previously well-established criteria (Leigh et al., 2010) with the same
virulent wild-type strain 0140J previously used in a number of
challenge experiments (Field et al., 2003; Leigh et al., 2010; Smith
et al., 2003). Bacteria were grown overnight in THB at 37 uC, and cells
were recovered by centrifugation (10 000 g, 10 min) and resuspended
in pyrogen-free saline (Sigma). Cell suspensions were diluted to
approximately 1000 c.f.u. ml21 and held on ice, and the number of
viable bacteria was determined from aliquots prior to and post
challenge. Animals were challenged in mammary quarters by infusion
of 1 ml of the suspension; one animal was challenged in two
mammary quarters with 16103 c.f.u. of strain 0140J, and two
animals were challenged each in two mammary quarters with a
similar dose of the Vru mutant.
Following challenge, animals were milked and inspected twice daily
(07 : 00 h and 15 : 30 h) and were treated with appropriate antibiotics
once clinical end points had been reached using criteria previously
described (Field et al., 2003; Leigh et al., 2010), including the presence
of clotted/discoloured milk and a swollen udder quarter. Milk
samples were taken at each milking and analysed for the presence of
bacteria and somatic cells. The number of viable bacteria present was
estimated by direct plating of up to 1 ml of each milk sample onto
ABA. Samples were also diluted in saline, and 50 ml of each dilution
plated directly onto ABA. In each case, the presence and/or number of
S. uberis was determined, and the genotype of the recovered isolates
was determined by RFLP analysis (Hill & Leigh, 1989) and PCR
amplification of the vru locus. The number of somatic cells present in
milk samples was determined using a DeLaval portable cell counter in
line with the manufacturer’s instructions.
Production of recombinant Sub0145, Sub0888 and Sub1095
and corresponding antisera. The predicted mature CDS of Lbp/
Sub0145 was amplified from genomic DNA (S. uberis 0140J) by PCR
using the primer pair 59-GAAGATTTATTTACTATAAATAATTCAG-
39 and 59-TAGGAAAGTTTCTGGTACCCCTTTGTTA-39 to generate
an amplicon incorporating a KpnI restriction site for efficient di-
rectional cloning into a PvuII, KpnI and alkaline phosphatase
(New England Biolabs) treated pQE1 vector (Qiagen). Similarly, the
Sub1095 CDS was amplified using the primer pair 59-CAAAT-
GCCAAGTCATTCTCATC-39 and 59-CGCTTAATCACAAGGTAC-
CTCTGA-39 with an incorporated KpnI restriction site. Amplification
of the predicted mature CDS of Sub0888 was performed using the
primer pair 59-GAAGAAGTAGTGTCTTCATTAGGG-39 and 59-
CATCTTATTTGGTCGACTACTCTTC-39, incorporating a SalI res-
triction site for efficient directional cloning into a PvuII, SalI and
alkaline phosphatase-treated pQE1 vector. Ligated plasmid was
generated, desalted and transformed into E. coli M15 pREP4
(Qiagen). Recombinant clones were selected on LB kanamycin
(25 mg ml21) ampicillin (50 mg ml21) agar plates. Overnight cultures
containing each recombinant (66His-tagged) protein were subcul-
tured by dilution (1 : 30) into LB broth containing 50 mg ampicil-
lin ml21 and 25 mg kanamycin ml21 and grown at 37 uC with
agitation (200 r.p.m.) for 2 h. Expression of the recombinant
proteins, subsequent purification and generation of antisera were
performed as described previously (Egan et al., 2010).
Preparation of bacterial extracts and immunoblot analysis.
Culture supernatant samples from S. uberis 0140J and vru mutant
strains grown in THB to early exponential (OD550 0.42) and late-
exponential (OD550 0.75) growth phases were harvested following
centrifugation (16 000 g, 10 min). Complete Protease Inhibitor
(Roche Diagnostics) was added to the supernatant, which was
subsequently filter-sterilized through a 0.22 mm pore-size filter
(Millipore), and proteins therein were concentrated by precipitation,
as previously described (Egan et al., 2010). Concentrated supernatant
proteins were resuspended in SDS-loading buffer and separated by
SDS-PAGE using 15% (w/v) polyacrylamide gels. Proteins were
subsequently either stained with InstantBlue (Expedeon Protein
Solutions) or transferred (200 mA for 1 h in a Transblot apparatus,
Bio-Rad) in transfer buffer [25 mM Tris base, 192 mM glycine, 20%
(v/v) methanol, pH 8.1–8.4] to nitrocellulose membranes for
immunoblotting.
Membranes were incubated in a blocking solution [0.5% skimmed
milk (Marvel) in PBS] at 4 uC overnight, washed three times for
5 min (PBS containing 0.1% Tween-20; PBST) and then incubated
for 1 h with anti-Lbp rabbit antisera (1 : 10 000 in blocking solution)
or anti-PauA EC3 (Leigh, 1994) mouse monoclonal antibody (1 : 1000
in blocking solution). Membrane washes were repeated following
incubation with either goat anti-rabbit IgG conjugated to horseradish
peroxidase (HRP; Southern Biotech) or rabbit anti-mouse IgG
conjugated to peroxidase (Sigma), each diluted 1 : 1000 in blocking
buffer, for 1 h. Membranes were washed (as above) and HRP
conjugate was detected following incubation in 4-chloronaphthol
(0.5 mg ml21) containing methanol [16.7% (v/v)] and H2O2
[0.00015% (v/v)] under dark conditions for 1 h. Membranes were
subsequently rinsed in PBS and allowed to dry, and were stored under
light-tight conditions.
Detection of bacterial proteins on whole cells by ELISA. S.
uberis strains were grown until they reached OD550 0.42 or 0.75, and
cultures were centrifuged (16 000 g, 5 min) and bacterial pellets
washed in PBS, then recentrifuged, as before. Bacteria were
resuspended in ELISA coating buffer (carbonate/bicarbonate buffer,
pH 9.6; Sigma) and each suspension was adjusted to OD550 1.
Triplicate wells were coated with 100 ml of each bacterial strain and
incubated at 4 uC overnight. Wells were washed five times with
PBST, and 300 ml blocking solution [0.5% (w/v) casein/PBS] was
added and plates were incubated at 4 uC overnight. Blocked wells
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were washed as above and individual antisera added at the following
concentrations: anti-Sub0145 1 : 4000, anti-Sub0826 (Egan et al.,
2010) and anti-Sub0888 1 : 2000, and anti-Sub1095 1 : 500 in
blocking solution, and plates were incubated for 1 h at room
temperature. After repeated washes with PBST, 100 ml anti-rabbit–
HRP conjugate (Sigma) was added at a dilution of 1 : 5000 in
blocking solution to each well and incubated at room temperature
for 1 h. Wells were then emptied and reactions developed by adding
100 ml 3,39,5,59-Tetramethylbenzidine (TMB) Liquid Substrate
(Sigma) and stopped by the addition of 100 ml Stop Reagent for
TMB Substrate (Sigma). The colorimetric reaction was measured by
A450, and differences between datasets were assessed using one-way
ANOVA followed by Tukey’s multiple comparisons to determine
statistically significant values between each mutant strain and test
antigen.
RESULTS
Comparison of bacterial virulence by
experimental challenge with S. uberis 0140J and
Vru mutant
The virulence of the S. uberis 0140J strain and that of the
mutant with a defective virulence regulatory gene (vru,
sub0144) was assessed using a well-established experimental
model for bovine mastitis (Field et al., 2003; Leigh et al.,
2010; Smith et al., 2003). The Vru mutant contained an
insertional disruption (the 8 bp repeat signature of which
spanned from 25 bp upstream of the ATG start codon
to +3 bp), which was confirmed by PCR and DNA
sequencing (data not shown).
Both challenged quarters of the animal that received wild-
type S. uberis became infected and shed bacteria at around
16105 c.f.u. ml21 by 48 h post-challenge (Fig. 1a). Animals
challenged with the Vru mutant shed considerably fewer
bacteria in their milk. This low level of infection, which
remained consistent and detectable for the remainder of the
experiment (5 days), peaked at approximately 103 c.f.u.
ml21 by milking 5 (Fig. 1a).
The cellular infiltration into the mammary gland in response
to infection was markedly lower in quarters challenged with
the Vru mutant (Fig. 1b), with no overt clinical signs of
mastitis. In contrast, the animal challenged with the wild-
type strain showed clinical signs of mastitis (severe changes
in milk composition/colour and the inflammatory response
of the mammary gland) and required antibiotic treatment
after milking 4.
Comparison of differences in gene transcription
by microarray analysis
Gene expression profiles of S. uberis 0140J and isogenic
vru mutant were compared by microarray analysis using
a custom-designed S. uberis 0140J array optimized using
two different probes per gene to match individual genes
as determined from the genome annotation (Ward et al.,
2009). Two different growth time points were analysed
(early and late-exponential phases of growth), and genes
were considered to be differentially expressed in the
wild-type and mutant if the difference between the two
strains was greater than fourfold by analysis of the
duplicate probes for each gene and the comparison of the
datasets preferentially showed an adjusted P value of
,0.001.
Using these criteria, a total of 19 genes were found to be
expressed at lower levels by the Vru mutant, eight of which
(sub0051, sub0052, sub0145, sub1480, sub1174, sub1696,
sub1697 and sub1785) were common to both early and late-
exponential growth phases (Table 1). Genes relating to
capsule production (Ward et al., 2001), hasA and hasB1
(sub1697 and sub1696, respectively), were significantly and
substantially downregulated in the Vru mutant compared
with wild-type in both early (.250-fold) and late (.13-
fold) exponential phases of growth. Also, both pauA
(sub1785), previously shown to encode a plasminogen
activator (Rosey et al., 1999), and lbp (sub0145), encoding a
lactoferrin-binding protein (Moshynskyy et al., 2003), were
dramatically downregulated in the Vru mutant cultures
during early exponential growth (.100-fold) and to a
substantial, but lesser, extent (.20-fold) during late
growth periods. Pathway analysis showed differences in
the exponential phase of growth, where two pathways were
significantly downregulated in the Vru mutant compared
with the wild-type 0140J strain, i.e. the valine, leucine and
isoleucine biosynthesis and aminoacyl-tRNA biosynthesis
pathways (Table 2).
A number of CDSs were only differentially expressed in the
early exponential phase of growth; those downregulated in
the Vru mutant included sub0155, sub1095, sub1264 and
sub1025. Other CDSs (sub0176, sub0177, sub0543, sub0544,
sub1173, sub0118 and sub0137) were found to be down-
regulated in the Vru mutant only in the late-exponential
phase of growth.
A total of 24 genes were found to be expressed at higher
levels by the Vru mutant, 12 of which were common to both
early and late-exponential growth (Table 3). A number of
these genes were involved in purine biosynthesis, including
purH, purN, purF, purM, purC, purK, purE, purB and purD.
Pathway analysis unsurprisingly indicated that the Sub00230
purine metabolism pathway was upregulated in the absence
of functional vru at both time points, but also identified that
the Sub00061 fatty acid biosynthesis pathway was also
significantly upregulated in the absence of Vru at the
stationary growth phase (Table 2).
Detection of proteins in concentrated culture
supernatants of the wild-type and Vru-deficient
mutant and whole-cell ELISA
Mouse monoclonal antibody directed towards PauA
(Sub1785) was used to detect the presence of PauA in
concentrated culture supernatants of S. uberis 0140J and
the Vru mutant (Fig. 2a). Similarly, rabbit antisera directed
against Lbp (Sub0145) were used to detect the presence of
S. A. Egan and others
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Lbp (Fig. 2b). In each case, proteins corresponding to the
approximate sizes of the secreted versions of the PauA
(30.6 kDa) and Lbp (54.6 kDa) proteins were detected in
culture supernatant from the wild-type strain, although no
cross-reactive proteins were evident in that from the Vru
mutant strain.
As a number of the differentially expressed gene products
(Sub0145, Sub0826 and Sub1095) were known to be
anchored to the cell wall by SrtA in S. uberis (Egan et al.,
2010), the presence of these proteins on whole cells was
determined by ELISA (Fig. 3). By way of comparison, a
similarly anchored gene product (Sub0888) that appeared
from the microarray analysis to be unaffected by the
absence of Vru was also assayed by whole-cell ELISA. In
each case the reactions of the wild-type and Vru mutant
were compared with that of a relevant specific CDS mutant
previously shown to lack the gene product of interest
(Leigh et al., 2010).
Sub0145 was only detected on the wild-type strain (Fig.
3a); the level of reaction for the Vru mutant being similar
to that for the Sub0145-negative mutant. The Sub0826
protein (Fig. 3b) was detectable on both the wild-type and
the Vru mutant, but at significantly higher levels on the
Vru mutant compared with the wild-type. Conversely, the
Sub1095 protein, which was also detected on both strains
(Fig. 3d), was detected at a higher level on the wild-type
than on the Vru mutant. The Sub0888 protein was detected
on both strains at a similar level (Fig. 3c).
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Fig. 1. Bacterial isolation and somatic cell count following challenge with S. uberis 0140J and Vru mutant in dairy cattle. (a)
Bacterial recovery of S. uberis, quantified after each milking following challenge. Data are represented as the number of bacteria
obtained from the milk of animals challenged with either strain 0140J (n52) or the Vru mutant (n54) from each individual
challenged quarter, as indicated above. (b) Cellular influx measured after each milking following challenge. Data are represented
by the number of somatic cells (somatic cell count; SCC) obtained from the milk of animals challenged with either strain 0140J
(n52) or the Vru mutant (n54) from each individual challenged quarter, as indicated above.
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DISCUSSION
The ability of S. uberis to survive and/or proliferate within a
range of external environments and in various host niches is
critical for the continued persistence of this opportunistic
pathogen. Such adaptation requires co-ordinated regulation
of gene expression in response to differing conditions (Ward
et al., 2009). Survival and transmission of the pathogen
between cattle may be further enhanced by the ability to
control and co-ordinate virulence. In modern dairy settings,
overtly infected/diseased cattle may be treated with anti-
microbial compounds to eliminate the infection; however,
Table 1. Differentially transcribed genes expressed at a higher level in early and late-exponential phase cultures of S. uberis 0140J
compared with the S. uberis Vru mutant
Gene* Protein annotation Early exponential growth phase Late-exponential growth phase
Fold changeD P valued Fold changeD P valued
hasA/Sub1697 Hyaluronan synthase 380.0/250.2 ,0.001 17.9/13.8 ,0.001
hasB1/Sub1696 UDP-glucose 6-dehydrogenase 1 366.0/357.9 ,0.001 8.5/8.1 0.006/,0.001
lbp/Sub0145 Lactoferrin-binding protein 255.1/153.8 ,0.001 41.2/27.8 ,0.001/0.1262
pauA/Sub1785 PauA protein precursor
(streptokinase precursor)
169.6/168.3 ,0.001 32.1/23.6 ,0.001
Sub0051 Hypothetical protein 15.0/13.3 ,0.001 16.6/10.5 ,0.001/0.034
Sub0052 Membrane protein 14.8/14.5 ,0.001 13.4/8.5 ,0.001
Sub0177 RNA polymerase sigma factor protein – – 12.3/7.8 ,0.001
Sub0176 Exported protein – – 9.4/6.6 ,0.001
Sub1480 Permease 9.2/8.7 ,0.001 8.1/4.1 ,0.001
Sub1174 ABC transporter protein 8.3/4.2 0.033/0.002 16.4/12.9 ,0.001
Sub0543 Dihydroxyacetone kinase subunit
DhaK
– – 8.7/5.2 ,0.001
Sub1173 Membrane protein – – 8.5/6.7 0.027/,0.001
Sub0155 Basic membrane protein 8.1/7.7 ,0.001 – –
sclB/Sub1095 Collagen-like surface-anchored
protein
6.9/6.5 0.012/,0.001 – –
pyrD/Sub1264 Dihydroorotate dehydrogenase 1A 6.0/5.3 ,0.001 – –
Sub0118 Competence protein – – 5.6/4.5 ,0.001
pyrF/Sub1025 Orotidine 59-phosphate
decarboxylase
5.4/5.0 ,0.001 – –
Sub0544 Dihydroxyacetone kinase family
protein
– – 4.9/4.4 ,0.001
Sub0137 Lipoprotein – – 4.1/4.0 ,0.001
*Gene and protein annotation according to the genomic sequence of S. uberis 0140J (Ward et al., 2009).
DMean fold change represented by S. uberis 0140J versus the S. uberis vru mutant for each of the probes tested.
dWhere the P value for data from one of the two probes is not in excess of 0.001, the mean of both P values is provided.
Table 2. CORNA-based pathway analysis for early and late-exponential phase cultures of the S. uberis Vru mutant compared with S.
uberis 0140J
Pathway regulation in Vru
mutant compared with
wild-type strain
Pathway Total genes
involved in
pathway
Expectation Observation Fisher
distribution P
value
Downregulated in early
exponential growth phase
Sub00290; valine, leucine and
isoleucine biosynthesis
7 2 7 0.013
Downregulated in early
exponential growth phase
Sub00970; aminoacyl-tRNA
biosynthesis
25 7 16 0.015
Upregulated in late-exponential
growth phase
Sub00230; purine metabolism 47 13 28 ,0.0002
Upregulated in late-exponential
growth phase
Sub00061; fatty acid
biosynthesis
12 3 11 ,0.0002
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from an evolutionary standpoint, the ability to colonize the
mammary gland at high levels, coincidentally resulting in
disease in the host, may favour transmission of the
bacterium between individuals or niches.
The importance of the putative stand-alone gene regulator
Vru for virulence of S. uberis was demonstrated in the
current study. None of the bovine mammary quarters
challenged with the Vru mutant showed high-level bac-
terial colonization or overt signs of mastitis; in contrast,
those that received the genetically intact wild-type strain
shed bacteria at high levels and displayed clinical signs
similar to those previously reported following intra-
mammary challenge with S. uberis (Field et al., 2003;
Leigh et al., 2010).
The vru sequence exhibits a good level of homology to
other stand-alone gene regulators of streptococci, mga and
mgc (Caparon & Scott, 1987; Geyer & Schmidt, 2000), both
of which positively influence expression of virulence-
related sequences. Consistent with a role as a specific gene
regulator, the absence of Vru in S. uberis resulted in altered
levels of transcription from 42 CDSs. Of these, 19 CDSs,
including five that corresponded to the production of pu-
tative virulence determinants of streptococci, were tran-
scribed at lower levels in the absence of Vru. Conversely, 24
CDSs with higher levels of transcription were identified. It
was not determined whether Vru directly or indirectly
altered gene expression, but the presence of both positively
and negatively altered transcription may be indicative of
secondary regulatory events. To further substantiate this
Table 3. Differentially transcribed genes expressed at a higher level in early and late-exponential phase cultures of the S. uberis Vru
mutant compared with S. uberis 0140J
Gene* Protein annotation Early exponential growth
phase
Late-exponential growth
phase
Mean fold
changeD
Mean P
valued
Mean fold
changeD
Mean P
valued
purH/Sub0030 Bifunctional phosphoribosyl-
aminoimidazolecarboxamide formyltransferase/
IMP cyclohydrolase
91.1/90.0 ,0.001 14.8/12.2 ,0.001/0.065
Sub0865 Guanosine 59-monophosphate oxidoreductase 83.1/75.9 ,0.001 8.2/7.1 ,0.001
purN/Sub0029 Phosphoribosylglycinamide formyltransferase 72.8/63.1 ,0.001 10.9/9.1 ,0.001
purF/Sub0027 Amidophosphoribosyltransferase 69.8/67.9 ,0.001 31.0/29.7 ,0.001
purM/Sub0028 Phosphoribosylaminoimidazole synthetase 67.7/65.0 ,0.001 21.4/8.6 0.033/0.011
Sub0026 Phosphoribosylformylglycinamidine synthase
protein
60.0/21.5 ,0.001 50.7/40.8 ,0.001
purC/Sub0025 Phosphoribosylaminoimidazole-
succinocarboxamide synthase
20.0/18.0 ,0.001 61.7/55.3 ,0.001
purA/Sub0152 Adenylosuccinate synthetase 18.9/15.5 ,0.001 – –
Sub0987 Hypothetical protein 14.8/13.6 ,0.001 – –
purK/Sub0055 Phosphoribosylaminoimidazole carboxylase
ATPase subunit
12.0/11.3 ,0.001 21.2/13.2 ,0.001
purE/Sub0054 Phosphoribosylaminoimidazole carboxylase
catalytic subunit
8.2/7.6 ,0.001 23.4/20.4 ,0.001
purB/Sub0056 Adenylosuccinate lyase 7.0/6.5 ,0.001 4.9/4.7 ,0.001
purD/Sub0053 Phosphoribosylamine-glycine ligase 7.0/6.7 ,0.001 18.9/18.0 ,0.001
Sub0410 Membrane protein 7.0/6.3 ,0.001 4.5/4.3 ,0.001
Sub0411 PAP2 superfamily protein 6.1/5.9 ,0.001 – –
Sub0826 Surface-anchored subtilase family protein – – 6.6/6.1 ,0.001
fhs1/Sub0942 Formate-tetrahydrofolate ligase – – 6.1/5.8 ,0.001
spxA/Sub1777 Transcriptional regulator Spx 5.9/5.6 ,0.001 – –
Sub0746 Membrane protein 5.4/4.3 ,0.001 – –
Sub1260 Formate/nitrite transporter family protein 4.9/4.4 ,0.001 – –
fabD/Sub1497 Malonyl-CoA-acyl carrier protein transacylase – – 4.7/4.7 ,0.001
fabK/Sub1498 Enoyl-ACP reductase – – 4.4/4.3 ,0.001
Sub1233 Major facilitator superfamily protein 4.3/4.2 ,0.001 – –
rpmB/Sub0331 50S ribosomal protein L28 4.2/4.2 0.01/,0.001 – –
*Gene and protein annotation according to the genomic sequence of S. uberis 0140J (Ward et al., 2009).
DMean fold change represented by S. uberis 0140J versus the S. uberis vru mutant for each of the probes tested.
dWhere the P value for data from one of the two probes is not in excess of 0.001, the mean of both P values is provided.
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view, two CDSs with altered expression in the Vru mutant
showed homology to other known regulatory elements.
Transcription of a gene encoding an RNA polymerase sig-
ma factor was suppressed, whereas that encoding a putative
transcriptional regulator, spxA (Kajfasz et al., 2009), was
enhanced.
In the context of the current investigation it is difficult to
envisage how enhanced transcription would mediate a
reduction in virulence, but it was of interest to note that 10
of the 23 CDSs showing upregulation in the absence of
Vru were identifiably associated with purine biosynthesis.
These fell into two gene clusters: sub0025–sub0030, carry-
ing purCFMNH and the unassigned CDS sub0026; and
sub0053–sub0056, carrying purDEKB. A further purine
biosynthesis-related sequence, sub0152/purA, located at a
distant locus was also upregulated, indicating co-ordinate
regulation. Lesions within purine metabolism (purM,
purC) resulting in gene disruption have been shown to
affect growth in raw bovine milk (Smith, 2000), but
unsurprisingly, no such effect was noted for the Vru
mutant.
One highly downregulated sequence, lbp, was adjacent to
vru within the S. uberis genome. We speculated whether
mutation of vru may physically affect transcription from
lbp by preventing read through of a single transcript. To
investigate this, the 303 bp intergenic region (nucleotides
146 540–146 843 on the 0140J genome sequence) separating
sub0144/vru and sub0145 was scanned in both direc-
tions for bacterial promoter sequences using BPROM and
displayed using the Artemis program (Fig. 4) to illustrate
promoter sequence orientation with respect to the flanking
CDSs. Sequence analysis of this intergenic region identified
two divergent pairs of candidate promoter sequences.
This further substantiated the assertion that disruption of
the vru ORF in the vicinity of its start codon was likely to
be influencing sub0145 expression through altered expres-
sion of its gene product, rather than abrogation of a
possible shared transcriptional promoter. Furthermore,
similarly altered expression of Sub0145 protein was seen in
immunoblots of concentrated media proteins in a second
sub0144 mutant background where the ISS1 insertion
mapped to a position distant from candidate promoter
sequences (within 100 bp of the stop codon of sub0144),
which further excludes the possibility that both CDSs were
transcribed from a shared divergent promoter (data not
shown).
In GAS, the Mga regulator controls expression of a number
of major virulence determinants, including M protein, C5a
peptidase, ScpA, and collagen-like binding protein SclA
(Barnett & Scott, 2002; Caparon & Scott, 1987; Chen et al.,
1993; Rasmussen et al., 2000). Analysis of the S. uberis
genome did not reveal a gene encoding M protein but did
indicate a C5a peptidase-like precursor (Sub1154) and a
collagen-like binding protein (Sub1095) (Egan et al., 2010;
Ward et al., 2009). Unlike the situation with Mga in GAS,
Vru did not appear to influence the expression of Sub1154,
but did appear to alter expression of the collagen-like
protein, which was downregulated at the transcriptional
level during early exponential growth.
Hondorp & McIver (2007) speculated that only those CDSs
that show high-level activation/suppression in the pres-
ence/absence of Mga (respectively) are under its direct
control. A similar consideration of the data from this study
would suggest that genes encoding production of capsule,
plasminogen activator and lactoferrin-binding protein are
those most likely to be under the direct control of Vru.
The sequences downregulated in the absence of Vru
responsible for production of capsule, hasA and hasB1
(Ward et al., 2001), plasminogen activator, pauA (Leigh,
1994; Rosey et al., 1999), lactoferrin-binding protein, lbp,
and collagen-like protein, Sub1095 (Ward et al., 2009),
have been subject to previous investigation to determine
their individual roles in virulence (Field et al., 2003; Leigh
et al., 2010; Ward et al., 2003). While Lbp and the collagen-
like protein have been shown to be required for the full
expression of the virulent phenotype of S. uberis (Leigh
et al., 2010), the absence of PauA or capsule alone was not
deemed to affect virulence in lactating cattle (Field et al.,
2003; Ward et al., 2003).
The transcriptional data relating to lbp, pauA and Sub1095,
the collagen-like protein gene, were validated with respect
to their effect on protein expression. In the absence of Vru,
neither PauA nor Lbp was detectable, and the collagen-like
protein, which was detected on whole cells, was shown to
be present at a significantly lower level. These data, along
with that related to Sub0826 (upregulated in the absence
of Vru) and Sub0888 (unaffected by Vru), were consis-
tent with their comparative transcriptional levels in the
Fig. 2. Identification of PauA and Lbp from extracts of S. uberis
0140J and Vru mutant. Immunoblots of protein extracts from S.
uberis 0140J and the Vru mutant probed with either mouse
monoclonal antibody generated against PauA (Sub1785) (a) or
rabbit antisera generated against Lbp (Sub0145) (b). Precipitated
media extracts from the late-exponential growth phase (OD550
0.75) from the Vru mutant (lane 1) and 0140J (lane 2) were
analysed; molecular mass standards are indicated.
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Fig. 4. Highlighted promoter regions of the S. uberis 0140J, sub0144 and sub0145 genes. Snapshot of the Artemis program in
database mode displaying the S. uberis 0140J chromosome, with the genes and s70-type promoter regions of both sub0144
(vru) and sub0145 (lbp) with their orientation shown with respect to the flanking CDSs. The ”10 box 59-CATCATAAT-39 and a
”35 box, 59-TTGAAG-39, can be seen on the negative strand upstream of the vru start codon, whilst the corresponding
promoter sequences are identified on the positive strand upstream of the sub0145 gene. The location of the mutation in the
sub0144/vru gene is also highlighted.
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Fig. 3. Differential protein expression between S. uberis 0140J and Vru mutant. Whole-cell ELISA was used to detect protein
expression by S uberis 0140J wild-type and Vru mutant strains for Sub0145 (a), Sub0826 (b), Sub0888 (c) and Sub1095
(d). Results are expressed as the means of triplicate values; error bars, SD. In each ELISA, statistical significance was
determined by ANOVA and Tukey’s multiple comparison, with triple asterisks indicating a P value of ,0.001. The analysis
displayed is between strains at same growth point, with each strain statistically significantly different from the individual mutant
strain (P,0.001) in each assay, except in (a), in which the significant difference between the Vru mutant and Sub0145 mutant
was at P,0.01.
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presence/absence of Vru, thus indicating that transcrip-
tional analysis was reflected in protein expression.
It is possible that the reduced virulence observed for the
Vru mutant during this study was solely due to reduced
expression of Lbp. A mutant strain in the same genetic
background (strain 0140J) that lacks the ability to produce
Lbp has been shown to be of reduced virulence. This
mutant, like the Vru mutant, is less able to colonize the
lactating bovine mammary gland, and induces a lesser
inflammatory response (lower somatic cell count) and
fewer clinical signs than the wild type (Leigh et al., 2010).
However, any reduction in virulence of the Vru mutant
due to the absence of Lbp may be augmented by the
reduction in expression of the collagen-like protein
(Sub1095), the absence of which has been shown to affect
both colonization at high bacterial numbers and bacterial
persistence within the bovine mammary gland (Leigh et al.,
2010). Although the precise mechanism by which these two
proteins exert their effects on pathogenesis is currently
unknown, it is unlikely that they show redundancy in their
mechanisms, as the absence of each alone measurably
reduced virulence. Consequently, it is likely that the
absence (or reduced expression) of both has a greater
effect on virulence than the absence (or reduced expres-
sion) of either alone.
A possible role for either capsule and/or the plasminogen
activator PauA is more speculative. Whilst attractive as
virulence determinants, neither has been shown indepen-
dently to alter the virulence of S. uberis (Field et al., 2003;
Ward et al., 2003), implying that either these proteins do
not have a function in pathogenesis or that they exert any
effect in a highly redundant manner alongside other
molecules.
The hyaluronic acid capsule of a number of streptococcal
species has been implicated in disease pathogenesis, linked
to invasion, adherence and evasion of phagocytic host
defences. Capsule production in S. uberis has been shown
to be dependent on hasA and hasC (Ward et al., 2001).
This is distinct from the situation with GAS, in which
capsule expression is dependent on hasA and hasB but not
hasC. S. uberis carries a homologue of hasB (sub1027/
hasB2) elsewhere within the genome (Ward et al., 2009),
and unlike GAS does not appear to encode another means
of producing UDP-glucose, the chemical product resulting
from the action of HasC. Therefore, of the genes required
for capsule production in S. uberis, only hasA (as part of
the hasAB1 gene cluster) showed significantly reduced
transcription in the Vru mutant; hasC, located around 3 kb
downstream from the hasAB1 gene cluster and hasB2,
showed no marked differences in expression in the absence
of Vru. Mutation of hasA in the same genetic background
(strain 0140J) as used in the present study has been shown
experimentally not to alter virulence. The hasAB1 gene
cluster is not universally present in S. uberis, although this
operon has been shown to be over-represented in isolates
from clinically apparent infections (Field et al., 2003).
Together, these data imply some level of evolutionary
significance with respect to virulence; however, the precise
role of the capsule, and whether it acts a genetic marker of
other, more functional, CDSs remain to be determined.
Streptococcal species have evolved, or acquired by
horizontal gene transfer, a number of apparently distinct
products that typically activate plasminogen in a species-
specific manner that invariably includes that from the
target species (Caballero et al., 1999; Kinnby et al., 2008;
Leigh et al., 1998). Indeed, different strains of S. uberis have
been shown to possess two different and mutually exclusive
CDSs encoding distinct products, PauA and PauB (Rosey
et al., 1999; Ward & Leigh, 2002). Parallel evolution and/or
acquisition and retention of such CDSs imply the utility of
the activity, a view that is further reinforced by the
apparent lack of variation within a selection of PauA
sequences analysed (Ward & Leigh, 2004). However
disabling mutations of PauA in S. uberis have no effect
on virulence in lactating dairy cattle, indicating that any
role for this activity is not linked to virulence within the
lactating bovine mammary gland (Ward et al., 2003).
Again, the presence of PauA (or PauB) is not ubiquitous in
S. uberis, although it appears to be present in more than
90% of the isolates investigated (Ward & Leigh, 2002), a
greater proportion than have acquired (and retained) the
hasAB1 gene cluster.
Of the remaining CDSs that were downregulated in the
absence of Vru, none has previously been shown to affect
virulence or have any putative or speculated role regarding
the host–pathogen interaction. Some gene products were
putatively involved in solute transport via ABC type
transporters (Sub0137, 1174 and 1173), while others were
linked to metabolism of pyrimidines (Sub1264 and 1025).
However, these did not affect growth of the Vru mutant in
either THB or milk.
In conclusion, it would appear justified to speculate that
the observed reduced virulence of an S. uberis Sub0144
(Vru) mutant was mediated largely by its effect on
expression from the adjacent CDS (Sub0145), encoding a
surface-anchored protein shown by others to bind
lactoferrin (Moshynskyy et al., 2003). Such effects could
be further enhanced by the concomitant reduced expres-
sion of a collagen-like protein. The apparently co-
ordinated regulation of putative virulence determinants
that are not directly linked with virulence, at least for the
lactating bovine mammary gland, may indicate that Vru
additionally or historically coordinates gene expression in
S. uberis for attributes other than virulence following
intramammary infection of the lactating bovine mammary
gland.
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